Welcome to Mol3D Research
Mol3D Research provides consultancy and research services in computational chemistry, molecular modeling and computer-aided drug design (CADD) for biotechnology and pharmaceutical companies, academic institutions, and non-profit research organizations involved in new drug discovery. We have extensive experience of working with multi-disciplinary teams, including medicinal chemists, biologists, pharmacologists and crystallographers, in support of drug discovery R&D projects for oncology, diabetes, CNS, virology and bacteriology. We offer comprehensive CADD services with special emphasis on structure-based drug lead discovery and optimization.
Mark Shenderovich, PhD, Principal and CSO of Mol3D Research, has 15 years of experience working as a computational chemist for biopharmaceutical industry, and more than 25 years of overall research experience in molecular modeling and CADD. He made a critical contribution to the discovery of clinical and pre-clinical drug candidates for Hsp90, protein tyrosine phosphatase, protease and protein kinase targets. He has extensive experience of working with multi-disciplinary teams, including medicinal chemists, biologists, pharmacologists, crystallographers and software developers. Click here for more details.